During the past decade, Orszagos Onkologiai Intezet; Borgyogyaszati Osztaly conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Orszagos Onkologiai Intezet; Borgyogyaszati Osztaly" are "Advanced BRAFV600 Wild-type Melanoma" (1 trials), "Cancer" (1 trials), "Melanoma" (1 trials) and "Metastatic Melanoma" (1 trials). Many other conditions were trialed in "Orszagos Onkologiai Intezet; Borgyogyaszati Osztaly" in a lesser frequency.

Most popular intervention types in "Orszagos Onkologiai Intezet; Borgyogyaszati Osztaly" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (4 trials), "Cobimetinib" (3 trials), "Vemurafenib" (2 trials), "Atezolizumab Placebo" (1 trials) and "Pembrolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Orszagos Onkologiai Intezet; Borgyogyaszati Osztaly" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Orszagos Onkologiai Intezet; Borgyogyaszati Osztaly". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Orszagos Onkologiai Intezet; Borgyogyaszati Osztaly, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Orszagos Onkologiai Intezet; Borgyogyaszati Osztaly, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".